Besides, patients with anti-MDA5 often have lymphopenia, increased serum levels of liver enzymes and hyperferritinemia, which may indicate that JDM patients with anti-MDA5 antibody are prone to MAS [35, 36]. This evidence concerns the gene IFIH1 and macrophage activation syndrome.